Study Title

A Phase 4 Open-Label Multicenter Study of PYLARIFY® PET/CT or PET/MRI in Men With Newly Diagnosed Favorable Intermediate Risk (FIR) Prostate Cancer

Study Details

Description:

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the prostate gland in men with favorable intermediate risk prostate cancer.

Sponsor:

Lantheus Medical Imaging

Contacts:

Senior Clinical Trial Manager

pyl4301studyinfo@lantheus.com

1(646) 975-2540

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468